Recently, the FDA approved a new cancer drug called Selinexor. This drug has been found to be successful in treating multiple myeloma in patients who have exhausted all other existing treatment options. Selinexor works on a different mechanism compared to other drugs. It enters a cell and targets mechanisms that move molecules into and out of the cell. We are talking to Dr. Dan Vogl, who lead the Phase II studies on Selinexor, on how the drug works, how it should be used, potential side effects and who should consider using it.